<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=457360127799285&amp;ev=PageView&amp;noscript=1">

Interested in a Diabetic research trial? Click here: I'M INTERESTED

header-img.png

Internal Medicine of Greater New Haven, LLC (IMGNH) has partnered with Chase Medical Research, LLC, a leader in dedicated research sites, to offer multi-therapeutic clinical trials to patients in greater New Haven.

The clinical research site in Hamden at 1952 Whitney Avenue (adjacent to the IMGNH office)  is currently enrolling patients in a variety of clinical trials and is staffed with experienced clinical research coordinators and physician investigators with a focus on quality and caring.

You may qualify to participate in one of our current clinical research trials of an investigational medication or one of our future trials.  There is no cost to you and you may also be compensated for travel.

CLINICAL TRIAL AREAS

We are currently recruiting participants for the diagnoses listed below at the Hamden location.  

Type 1 Diabetes (2 studies)

  • One trial is for patients who are 18-75 years old, have a diagnosis of type 1 diabetes, have an HbA1c less than or equal to 10%, are insulin dependent, and are not on an insulin pump.
  • One trial is for patients who are 18-40 years old, who were diagnosed with type 1 diabetes with the past 5 years, and are insulin dependent. Patients can be on an insulin pump; however, this is not required.

Type 2 Diabetes (2 studies)

  • One trial is for patients who are 18 years of age or older, have a diagnosis of type 2 diabetes, have an HbA1c between 7.0% and 10.5% inclusive,  and are currently only taking a stable dose of metformin greater than or equal to 1500 mg/day (unchanged for at least 3 months) to treat their diabetes.
  • One trial is for patients who are 18 years of age or older, have type 2 diabetes, have elevated triglycerides or cholesterol, have a low HDL-C (low "good" cholesterol), and have an HbA1c between 6.5% and 9.5% inclusive.

Diabetic Kidney Disease (DKD)

This trial is for patients who are 18-80 years old, have a clinical diagnosis of type 2 diabetes, and have moderate to severe chronic kidney disease. 

Migraine

This trial is for patients who are 18-65 years of age, were diagnosed prior to age 50, have had this diagnosis for at least 1 year, and have experienced on average between 2 and 8 migraine attacks per month over the past 3 months.

If you are interested in participating in any of these clinical trials or learning more, fill out the form.

See If You Qualify